## **Core Concept**
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) are a class of medications that inhibit the reuptake of both serotonin and norepinephrine neurotransmitters. This dual-action mechanism is utilized in the treatment of various conditions, including major depressive disorder, anxiety disorders, and certain types of chronic pain. SNRIs are often considered when selective serotonin reuptake inhibitors (SSRIs) are ineffective.

## **Why the Correct Answer is Right**
The correct answer, , is not an SNRI. To determine why, one would typically examine the pharmacological profile of each option. SNRIs are characterized by their ability to block the reuptake of both serotonin and norepinephrine. Without specific names provided for A, B, C, and D, a general understanding is that any option lacking this dual mechanism of action would not be classified as an SNRI.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Assuming A is an SNRI (e.g., venlafaxine, duloxetine), it would work by inhibiting the reuptake of both serotonin and norepinephrine, making it effective for conditions like depression and certain pain syndromes.
- **Option B:** Similarly, if B is another SNRI, its mechanism would align with the definition of SNRIs, making it incorrect as an answer to what is not an SNRI.
- **Option C:** If C is also an SNRI, then like A and B, it would not be the correct answer to this question.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while SNRIs are effective for a range of conditions, they can have a different side effect profile compared to SSRIs, partly due to their effect on norepinephrine. For example, SNRIs may be more likely to increase blood pressure and cause sweating.

## **Correct Answer:** .